about
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular CarcinomaTranslating neoadjuvant therapy into survival benefits: one size does not fit all.Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis.Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base.Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.Gout and subsequent erectile dysfunction: a population-based cohort study from England.Statins Are Associated With Reduced Mortality in Multiple Myeloma.Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myelomaMetabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanomaThe Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal CancerLow-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical TrialImmune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients.Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors ≤5 cm in the Modern Treatment Era: A Retrospective Korean Breast Cancer Society ReportNeoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer.Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.Does radiotherapy still have a role in unresected biliary tract cancer?Statistical methods for elimination of guarantee-time bias in cohort studies: a simulation study.Survival probabilities with time-dependent treatment indicator: quantities and non-parametric estimators.Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity.Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma.Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate CancerSuicide and violent deaths in survivors of cancer in childhood, adolescence and young adulthood-A national cohort study.Estimating the effect of immortal-time bias in urological research: a case example of testosterone-replacement therapy.Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma.Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands.Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: a subgroup analysis from AIO-PK0104.Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience.Association of Adjuvant Therapy with Improved Survival in Ampullary Cancer: A National Cohort Study.Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies.
P2860
Q26797535-94BD5F97-6AF7-474C-9925-CCA59392BAC6Q30251738-E2D900B1-2326-4607-8F6B-2CA6D6D0D957Q30992150-DBAE04AC-EB55-494B-B219-42D437792685Q31120524-628C3E9D-1DBF-423D-8A7C-BD7C94175D75Q31135072-CE9A8374-0408-40AF-B519-0235D99D0CC3Q33683120-C5186514-31C2-45BA-895B-18D0D2838694Q33771490-F26225EA-3E83-4855-98F8-4DDFE575A40BQ33816591-9B2AFEF5-37C4-486D-9462-289CAD97B98DQ33851726-1F729324-C584-4093-86FA-57B16B8CD40DQ33994341-42AE93DB-2006-4624-8260-B8C7AE31573DQ35093281-9080060B-9953-4068-B522-8A40842CBF6CQ35793080-434DFF10-A8ED-4213-B175-1155A19FAB0BQ36057458-013C39D4-C4BB-4B20-A3A2-152909C2D55DQ36360918-B32D60E3-DA93-4C31-A989-F417D4F34C08Q36482781-2BD23909-C120-40F2-9E16-F31281F2EB63Q36673860-D782E7D4-2700-44BB-A933-4251A66A4573Q36992766-5938EA9D-70F8-486F-A45F-5806C933D4FFQ36993433-9CBEEB3B-7029-4434-86E8-AF3E56E6720FQ37022428-B3AF23CC-B3FE-45AA-98B3-AFE520723394Q37222157-493B299C-8889-482B-939C-78964D2A1FF7Q37609455-082EE9BD-B7CE-44D1-97C5-7112D07085F3Q38613762-933F2916-9012-48CF-A110-A18D7686CED8Q38616796-C194B811-8C49-43D5-9EA4-0DDF5868B9BDQ38620191-2D03EC60-65CB-4D73-BD98-E4DA6382E8B3Q38661975-55D579DA-CE0E-48AA-AB93-7E34790B5988Q38847344-C51AC606-DF48-473B-9639-754651661221Q38950703-16866D71-DF21-441E-9E99-6F34A23307A1Q38968531-5D46D04D-3965-4038-96CA-6AD7E4A7F894Q38978471-447FB5B1-FD93-4C7C-9FBB-AA676C5A715FQ38984178-5E2D55ED-4AE0-45B6-B1E4-A641A3D4B571Q39280924-B433EBB4-4538-491F-929C-993549EBA244Q39332432-EFFBC4B2-E4B1-47BF-A21F-2B3E52B16F16Q39376084-0B595A60-C073-41B4-9956-1231F6DA868FQ39836265-90D806BD-6FD0-44B0-B516-6F788F79EA12Q40285529-D9354EB9-A7FF-41BF-A1C8-C70CE2076870Q40682861-BE48AFB1-E7F1-4A01-B436-BAF9E727125AQ40997435-974109C5-9E68-43BB-9788-C1975EF3C9C7Q47108532-0D235CD1-5738-46E6-98DA-FD7A4ED64442Q47614694-D46AF1D9-F458-4BE9-AD4D-D989192CFA22Q47668299-F06EA48B-9BC9-455C-B90D-D13F462D8A21
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Challenges of guarantee-time bias
@en
Challenges of guarantee-time bias.
@nl
type
label
Challenges of guarantee-time bias
@en
Challenges of guarantee-time bias.
@nl
prefLabel
Challenges of guarantee-time bias
@en
Challenges of guarantee-time bias.
@nl
P2093
P2860
P356
P1476
Challenges of guarantee-time bias
@en
P2093
Anita Giobbie-Hurder
Meredith M Regan
Richard D Gelber
P2860
P304
P356
10.1200/JCO.2013.49.5283
P407
P577
2013-07-08T00:00:00Z